Systemic lupus erythematosus associated with HIV infection: a retrospective case-control study.


Journal

Clinical and experimental rheumatology
ISSN: 0392-856X
Titre abrégé: Clin Exp Rheumatol
Pays: Italy
ID NLM: 8308521

Informations de publication

Date de publication:
31 Jan 2024
Historique:
received: 17 10 2023
accepted: 28 12 2023
medline: 19 2 2024
pubmed: 19 2 2024
entrez: 19 2 2024
Statut: aheadofprint

Résumé

The association of systemic lupus erythematosus (SLE) and human immunodeficiency virus (HIV) remains scarcely described in the literature. Our objectives were to describe the characteristics of SLE in patients living with HIV (SLE-PLHIV) and compare it with SLE characteristics in patients without HIV infection. We performed a retrospective study of 13 patients with SLE-PLHIV diagnosed between 1975 and 2020 in four different French hospitals. These patients were compared in a case-control study with a 1:5 ratio to age-, sex- and year of diagnosis- matched patients with SLE without HIV infection. Median (IQR) age at SLE diagnosis for patients with SLE and HIV infection was 43 years (36-53). There were 77% women. Main clinical manifestations were polyarthrtitis (84%), cutaneous lupus (69%), kidney disease (54%), serositis (15%) and autoimmune cytopenias (auto-immune haemolytic anaemia and/or immune thrombocytopenia) (31%). There were no neuropsychiatric manifestations. All patients had positive antinuclear antibody test with a titre ≥1:160. Anti-dsDNA antibodies were present in 75% of patients, and anti-Sm antibodies in 33%. SLE-PLHIV had more frequently renal manifestations (54 vs. 16%, p=0.006) and autoimmune cytopenia (31 vs 8%, p=0.04) than patients without HIV infection. SLE and HIV infection appear to be a rare association. Patients with SLE-PLHIV seem to have more renal manifestations and autoimmune cytopenias than patients with SLE without HIV infection.

Identifiants

pubmed: 38372716
pii: 20448
doi: 10.55563/clinexprheumatol/ujg828
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Matthias Papo (M)

Sorbonne Université, Assistance Publique - Hôpitaux de Paris, Groupement Hospitalier Pitié-Salpêtrière, Centre National de Référence pour le Lupus, le Syndrome des Anticorps Anti-phospholipides et Autres Maladies Auto-immunes Rares, Service de Médecine Interne 2, Institut E3M, Paris, France. matthias.papo@aphp.fr.

Julien Haroche (J)

Sorbonne Université, Assistance Publique - Hôpitaux de Paris, Groupement Hospitalier Pitié-Salpêtrière, Centre National de Référence pour le Lupus, le Syndrome des Anticorps Anti-phospholipides et Autres Maladies Auto-immunes Rares, Service de Médecine Interne 2, Institut E3M, Paris, France.

Damien Sene (D)

Université Paris-Cité, Département de Médecine Interne, Hôpital Lariboisière, Assistance Publique-Hôpitaux de Paris, Paris, France.

Lionel Galicier (L)

Assistance Publique-Hôpitaux de Paris, Département d'Immunologie Clinique, Hôpital Saint-Louis, Paris, France.

Philippe Remy (P)

Assistance Publique-Hôpitaux de Paris, Service de Néphrologie, Hôpital Henri Mondor, Paris, France.

Caroline Misslin (C)

Service de Médecine, Centre Hospitalier de l'Ouest Guyanais, Saint Laurent du Maroni, France.

Zahir Amoura (Z)

Sorbonne Université, Assistance Publique - Hôpitaux de Paris, Groupement Hospitalier Pitié-Salpêtrière, Centre National de Référence pour le Lupus, le Syndrome des Anticorps Anti-phospholipides et Autres Maladies Auto-immunes Rares, Service de Médecine Interne 2, Institut E3M, Paris; and Inserm UMRS, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France.

Alexis Mathian (A)

Assistance Publique - Hôpitaux de Paris, Groupement Hospitalier Pitié-Salpêtrière, Centre National de Référence pour le Lupus, le Syndrome des Anticorps Anti-phospholipides et Autres Maladies Auto-immunes Rares, Service de Médecine Interne 2, Institut E3M; and Inserm UMRS, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France.

Classifications MeSH